Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness
- PMID: 338489
- PMCID: PMC421292
- DOI: 10.1128/iai.18.3.701-707.1977
Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness
Abstract
Mice injected with 100 to 800 microgram of Cryptococcus neoformans soluble polysaccharide showed a reduced ability to produce antibody after a challenge immunization with polysaccharide emulsified in Freund incomplete adjuvant. These animals were considered immunologically unresponsive. Animals given an initial injection of 25 or 50 microgram of polysaccharide responded to a challenge immunization in the same manner as control animals. Reversion of unresponsive mice to antibody production without further antigenic stimulation did not occur during a 12-week experimental period. These animals exhibited a partial response to challenge immunization 8 weeks after induction of unresponsiveness, and they were fully responsive to challenge immunization at 12 weeks. Animals given a single dose of 0.1, 0.4, or 1.6 microgram of polysaccharide produced a marked anamnestic response after challenge immunization. Repeated injections of subimmunogenic doses of polysaccharide did not produce a marked anamnestic response and would induce unresponsiveness only when the cumulative dose reached 100 to 400 microgram of polysaccharide, suggesting that injected cryptococcal polysaccharide might be sequestered in some manner until an amount of antigen sufficient for induction of unresponsiveness is accumulated. This possibility was confirmed by immunofluorescence studies that revealed a long-term deposition of polysaccharide in the tubular epithelial cells of the kidney.
Similar articles
-
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses.Infect Immun. 1982 Apr;36(1):47-51. doi: 10.1128/iai.36.1.47-51.1982. Infect Immun. 1982. PMID: 6210638 Free PMC article.
-
Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans.Mycopathol Mycol Appl. 1974 Oct 15;54(1):21-30. doi: 10.1007/BF02055969. Mycopathol Mycol Appl. 1974. PMID: 4139653 No abstract available.
-
Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.Infect Immun. 1972 Jun;5(6):896-901. doi: 10.1128/iai.5.6.896-901.1972. Infect Immun. 1972. PMID: 4564405 Free PMC article.
-
Polysaccharide antigens of the capsule of Cryptococcus neoformans.Infect Immun. 1994 May;62(5):1507-12. doi: 10.1128/iai.62.5.1507-1512.1994. Infect Immun. 1994. PMID: 8168912 Free PMC article. Review.
-
Capsular polysaccharides of Cryptococcus neoformans.Rev Infect Dis. 1984 Sep-Oct;6(5):619-24. doi: 10.1093/clinids/6.5.619. Rev Infect Dis. 1984. PMID: 6209768 Review.
Cited by
-
Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.Infect Immun. 2002 May;70(5):2598-604. doi: 10.1128/IAI.70.5.2598-2604.2002. Infect Immun. 2002. PMID: 11953401 Free PMC article.
-
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses.Infect Immun. 1982 Apr;36(1):47-51. doi: 10.1128/iai.36.1.47-51.1982. Infect Immun. 1982. PMID: 6210638 Free PMC article.
-
Protective immunity against cryptococcus neoformans infection.Mcgill J Med. 2007 Jan;10(1):35-43. Mcgill J Med. 2007. PMID: 18523595 Free PMC article.
-
Cryptococcal capsular polysaccharide clearance in nonimmune mice.Mycopathologia. 1982 Apr 23;78(1):41-5. doi: 10.1007/BF00436580. Mycopathologia. 1982. PMID: 7048100
-
Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure.Mol Immunol. 2010 Apr;47(7-8):1421-5. doi: 10.1016/j.molimm.2010.02.018. Epub 2010 Mar 17. Mol Immunol. 2010. PMID: 20299100 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources